Mifobate, CAS 76541-72-5

Product Description: Mifobate (SR-202) is a potent and specific PPARγ antagonist. Mifobate (SR-202) selectively inhibits Thiazolidinedione (TZD)-induced PPARγ transcriptional activity (IC50=140 μM). Mifobate (SR-202) does not affect basal or ligand-stimulated transcriptional activity of PPARα, PPARβ, or the farnesoid X receptor (FXR). Mifobate (SR-202) shows antiobesity and antidiabetic effects[1].

Applications: Neuroscience-Neuromodulation

Formula: C11H17ClO7P2

References: [1]Rieusset J, et al. A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesityand antidiabetic activity. Mol Endocrinol. 2002 Nov;16(11):2628-44.

CAS Number: 76541-72-5

Molecular Weight: 358.65

Compound Purity: 99.10

Research Area: Metabolic Disease

Solubility: H2O : 35.87 mg/mL (ultrasonic;warming)/DMSO : 100 mg/mL (ultrasonic)

Target: PPAR

• Artikelnummer: MEXHY-100277-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-100277-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK